Regend Therapeutics
Clinical trials sponsored by Regend Therapeutics, explained in plain language.
-
Stem cell trial aims to regrow lungs in COPD patients
Disease control Recruiting nowThis early-phase trial tests REGEND007, a stem cell therapy made from airway cells, in 12 people with COPD. The cells are given by IV infusion in increasing doses to see if they are safe and can help repair lung damage. The study is still recruiting and focuses on safety first.
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Kidney repair cells tested in diabetes patients for first time
Disease control Recruiting nowThis early study tests a new treatment called REGEND003, made from human kidney progenitor cells, in 15 people with type 2 diabetes and chronic kidney disease. The main goal is to check if the treatment is safe and tolerable. Participants will receive either the cell therapy or a…
Phase: PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could stem cells repair damaged airways in kids?
Disease control Recruiting nowThis early-phase study tests whether airway basal stem cells can safely help children with bronchiolitis obliterans, a chronic lung disease that narrows airways. About 12 children aged 28 days to 18 years will receive the cells via bronchoscopy. Researchers will check for improve…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC